Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.610
+0.020 (1.26%)
At close: Jun 26, 2026, 4:00 PM EDT
1.630
+0.020 (1.24%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Autolus Therapeutics Employees
As of December 31, 2025, Autolus Therapeutics had 754 total employees, including 752 full-time and 2 part-time employees. The number of employees increased by 104 or 16.00% compared to the previous year.
Employees
754
Change (1Y)
104
Growth (1Y)
16.00%
Revenue / Employee
$122,844
Profits / Employee
-$383,243
Market Cap
428.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Adlai Nortye | 109 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| Cybin | 50 |
| Eupraxia Pharmaceuticals | 49 |
AUTL News
- 3 days ago - Autolus Therapeutics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 16 days ago - Autolus Therapeutics Receives Prix Galien UK Award - GlobeNewsWire
- 24 days ago - Autolus Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Autolus Therapeutics Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 4 weeks ago - Autolus Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Autolus Therapeutics price target raised to $10 from $9 at H.C. Wainwright - TheFly